New investigations have placed Hunter Company under close scrutiny concerning its pharmaceutical manufacturing and marketing methods. Claims regarding seemingly unconventional research protocols and aggressive marketing approaches have ignited broad unease among officials, investors, and patient advocacy groups. The matter is necessitating a detai